 Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- NIDDM
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
- Diabetes Mellitus, Noninsulin Dependent
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in Harvard Catalyst Profiles by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1983 | 1 | 2 | 3 | | 1984 | 3 | 2 | 5 | | 1985 | 3 | 1 | 4 | | 1986 | 4 | 3 | 7 | | 1987 | 6 | 2 | 8 | | 1988 | 8 | 5 | 13 | | 1989 | 5 | 1 | 6 | | 1990 | 5 | 4 | 9 | | 1991 | 14 | 6 | 20 | | 1992 | 20 | 8 | 28 | | 1993 | 10 | 5 | 15 | | 1994 | 19 | 8 | 27 | | 1995 | 24 | 7 | 31 | | 1996 | 21 | 11 | 32 | | 1997 | 23 | 5 | 28 | | 1998 | 32 | 14 | 46 | | 1999 | 32 | 10 | 42 | | 2000 | 36 | 12 | 48 | | 2001 | 50 | 11 | 61 | | 2002 | 69 | 27 | 96 | | 2003 | 82 | 28 | 110 | | 2004 | 90 | 29 | 119 | | 2005 | 92 | 34 | 126 | | 2006 | 126 | 21 | 147 | | 2007 | 152 | 41 | 193 | | 2008 | 158 | 40 | 198 | | 2009 | 154 | 35 | 189 | | 2010 | 190 | 43 | 233 | | 2011 | 200 | 39 | 239 | | 2012 | 231 | 56 | 287 | | 2013 | 249 | 44 | 293 | | 2014 | 239 | 57 | 296 | | 2015 | 236 | 38 | 274 | | 2016 | 159 | 41 | 200 | | 2017 | 43 | 14 | 57 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Zheng Y, Manson JE, Yuan C, Liang MH, Grodstein F, Stampfer MJ, Willett WC, Hu FB. Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life. JAMA. 2017 Jul 18; 318(3):255-269.
-
Barry MJ, Humphrey LL, Qaseem A. Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus. Ann Intern Med. 2017 07 04; 167(1):75-76.
-
Amri R, Dinaux AM, Kunitake H, Bordeianou LG, Berger DL. Risk Stratification for Surgical Site Infections in Colon Cancer. JAMA Surg. 2017 Jul 01; 152(7):686-690.
-
Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH, Centeno-Cruz F, Zerrweck C, Orozco L, Altshuler DM, Schreiber SL, Florez JC, Jacobs SBR, Lander ES. Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms. Cell. 2017 Jun 29; 170(1):199-212.e20.
-
Januzzi JL, Butler J, Jarolim P, Sattar N, Vijapurkar U, Desai M, Davies MJ. Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes. J Am Coll Cardiol. 2017 Aug 08; 70(6):704-712.
-
Florez JC. Mining the Genome for Therapeutic Targets. Diabetes. 2017 Jul; 66(7):1770-1778.
-
Sattar N, Petrie MC, Zinman B, Januzzi JL. Novel Diabetes Drugs and the Cardiovascular Specialist. J Am Coll Cardiol. 2017 May 30; 69(21):2646-2656.
-
Hwang TJ, Franklin JM, Kesselheim AS. Effect of US Food and Drug Administration's Cardiovascular Safety Guidance on Diabetes Drug Development. Clin Pharmacol Ther. 2017 Aug; 102(2):290-296.
-
Schauer PR, Bhatt DL, Kashyap SR. Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years. N Engl J Med. 2017 05 18; 376(20):1997.
-
St-Jean M, Boudreau F, Carpentier AC, Hivert MF. HNF1a defect influences post-prandial lipid regulation. PLoS One. 2017; 12(5):e0177110.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|